Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Sulfatrim pediatric side effects?

See the DrugPatentWatch profile for Sulfatrim

Sulfatrim (a fixed‑dose combination of sulfamethoxazole 1 : trimethoprim 5 : 1) is a common antibiotic used in children for urinary tract infections, ear infections, bronchitis, pneumonia, and certain types of gastroenteritis. While it is generally safe when prescribed appropriately, it can produce side effects that range from mild to potentially serious. Below is a concise but comprehensive overview of pediatric side effects, organized by severity and by patient age group.


1. Common (Mild) Side Effects

Symptom Typical Onset Frequency in Children Notes
Mild gastrointestinal upset (nausea, vomiting, diarrhea, abdominal discomfort) Usually within the first few doses 5‑15 % Often resolves when the dose is continued or the medication is taken with food.
Mild skin rash or pruritus (maculopapular rash) 1‑3 days 2‑5 % Typically benign; monitor for worsening or spreading.
Photosensitivity (sunburn‑like rash, increased sunburn risk) Within a few days < 2 % Counsel on sun protection (sunscreen, protective clothing).
Elevated liver enzymes (mild ALT/AST increase) 1‑2 weeks < 2 % Usually asymptomatic; monitor if therapy is prolonged.
Allergic‑type “flu‑like” symptoms (fever, malaise) First week < 5 % Usually self‑limited; consider evaluation if persistent.

What to watch for: Any rash that becomes extensive or is accompanied by fever, swelling, or breathing difficulty should prompt a call to your pediatrician.


2. Moderate Side Effects

Symptom Frequency Notes
Severe skin reactions (e.g., Stevens‑Johnson syndrome, toxic epidermal necrolysis) < 0.01 % Life‑threatening; requires immediate medical attention.
Allergic reactions (anaphylaxis, angioedema) < 0.1 % Can happen at any time; call 911 if swelling, wheezing, or trouble breathing.
Hyperuricemia (elevated uric acid) < 5 % May precipitate gout or renal stones in predisposed children.
Hyperkalemia < 2 % Especially in infants or patients with renal impairment.
Hepatotoxicity (transaminase elevations > 3 × upper limit) < 5 % Monitor liver enzymes in long‑term therapy.
Myelosuppression (anemia, leukopenia, thrombocytopenia) < 1 % Rare, but risk increases with higher doses or prolonged courses.
Nephrocalcinosis (kidney stone formation) < 1 % More common in young children or those on high doses.

When to seek care: If your child shows signs of breathing trouble, severe swelling, a sudden drop in appetite or activity, or persistent vomiting after starting the drug, call your doctor promptly.


3. Rare but Serious Side Effects

Symptom Incidence Special Pediatric Considerations
Aplastic anemia (bone marrow failure) < 0.001 % Can present with fever, infections, or bruising.
Hemolytic anemia (especially in G6PD‑deficient children) < 0.05 % Red flag: jaundice, dark urine, pallor.
Severe hyperbilirubinemia (neonates < 28 days) < 0.01 % Contraindicated in infants < 28 days due to risk of kernicterus.
Severe nephrotoxicity (renal failure) < 0.1 % Monitor urine output and electrolytes.
Severe cutaneous adverse reactions (DRESS syndrome) < 0.01 % Requires immediate discontinuation.

4. Age‑Specific Issues

Age Group Key Points
Neonates (< 28 days) Avoid unless no alternatives and under a pediatric nephrologist’s guidance; risk of kernicterus.
Infants (1 month–2 years) Watch for hyperbilirubinemia and jaundice; monitor liver function if therapy > 7 days.
Toddlers & Preschoolers (2–5 years) Dose adjustment based on weight; watch for skin reactions and GI upset.
School‑aged Children (5–12 years) Higher risk of photosensitivity; ensure sun protection.
Adolescents (13–18 years) Monitor for hyperuricemia; screen for G6PD deficiency if at risk.

5. Drug‑Drug Interactions & Special Precautions

Interaction Effect Pediatric Implication
Other sulfonamides (e.g., TMP‑SMX, sulfadiazine) ↑Risk of cumulative toxicity (rash, hematologic changes). Avoid overlapping use if possible.
Warfarin/Anticoagulants ↑INR, bleeding risk Not usually relevant in children, but watch for bleeding signs.
Cimetidine ↓Sulfamethoxazole clearance Higher plasma levels; consider dose adjustment.
Allopurinol ↑risk of severe skin reactions Avoid concurrent use.
NSAIDs ↑GI upset Take with food, consider alternative if GI symptoms.

6. Monitoring and Follow‑Up

Lab/Check Frequency Reason
Complete blood count (CBC) Baseline, week 1, then every 2 weeks if therapy > 2 weeks Detect anemia, leukopenia, thrombocytopenia.
Liver enzymes (AST/ALT) Baseline, week 1, then every 2 weeks for prolonged courses Detect hepatotoxicity.
Renal function (BUN/Cr) Baseline, week 1 Monitor for nephrotoxicity, especially in infants.
Urine test (protein, blood) If clinical suspicion of renal injury Detect nephrocalcinosis or hematuria.

7. Red‑Flag Symptoms to Call the Doctor Immediately

Symptom Why it matters
Severe rash (especially with fever, blisters, or peeling) Possible Stevens‑Johnson syndrome or DRESS.
Persistent vomiting or diarrhea > 48 h Dehydration or possible drug intolerance.
Jaundice (yellowing of skin/eyes) Hyperbilirubinemia or hepatic failure.
Unexplained bruising or petechiae Possible thrombocytopenia or bone marrow suppression.
Shortness of breath, wheezing, swelling of face/ lips Anaphylaxis.
Dark urine or pale stools Kidney or liver issues.

8. Bottom Line

  • Sulfatrim is generally well‑tolerated in children when used as directed.
  • Mild side effects (GI upset, rash, photosensitivity) are the most common and usually resolve on their own.
  • Severe reactions are rare but potentially life‑threatening; prompt medical evaluation is critical.
  • Monitoring (CBC, liver enzymes, renal function) is advisable for courses longer than 7 days or in children with


Other Questions About Sulfatrim :

What is sulfatrim pediatric? Sulfatrim pediatric coupon? Sulfatrim coupon? Sulfatrim price? Sulfatrim pediatric suspension? Sulfatrim cost? Sulfatrim pediatric?